Managed Care - November 2008 - (Page RSV20)

CONTINUING MEDICAL EDUCATION ASSESSMENT/EVALUATION/CERTIFICATE REQUEST Respiratory Syncytial Virus (RSV): Prevention Strategies and the Appropriate Identification of Vulnerable Populations CE Credit for Physicians/Pharmacists I certify that I have completed this educational activity and post-test and claim (please check one): I Physician credit hours I Pharmacist contact hours Signature: PLEASE PRINT CLEARLY 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. EXAMINATION: Place an X through the box of the letter that represents the best answer to each question on page 21. There is only ONE correct answer per question. Place all answers on this form. A. Was this publication fair, balanced, and free of commercial bias? I Yes I No If no, please explain: Please use the following scale to answer the next four questions: First name, MI Last name, degree Title Affiliation Mailing address City State ZIP Daytime telephone ( ) Fax ( ) E-mail Physicians — This activity is designated for a maximum of 1.50 AMA PRA Category 1 Credit(s).™ Pharmacists — This activity is approved for 1.50 contact hours (0.150 CEU). ACPE Universal Program Number (UPN): 812-000-08-024-H01-P Release Date: Nov. 20, 2008 Expiration Date: Nov. 20, 2009 To receive a statement of credit, complete the assessment/evaluation form and mail or fax the completed form to: The Chatham Institute 26 Main Street, Suite 350 Chatham, NJ 07928 Fax: (973) 701-2515 Allow 6–8 weeks for processing. This activity is sponsored by The Chatham Institute and is provided at no cost to the participant through an educational grant from MedImmune. I I I I I I I I I I I I B. I I I I I I I I I I I I C. I I I I I I I I I I I D. I I I Strongly Agree 5 Agree 4 Neutral 3 Disagree 2 Strongly Disagree 1 Did this educational activity meet my needs, contribute to my personal effectiveness, and improve my ability to: Treat/manage patients? 5 4 3 2 1 N/A N/A N/A PROGRAM EVALUATION So that we may assess the value of this self-study program, we ask that you please fill out this evaluation form. Have the objectives for the activity been met? 1. Explain the epidemiology, burden of disease, and seasonal and regional variability of RSV. I Yes I No Communicate with patients? 5 4 3 2 1 Manage my medical practice? 5 4 3 2 1 Other 5 4 3 2 1 N/A 2. Discuss the economic impact of RSV on the health care system. I Yes I No 3. Explain which populations are at high risk of RSV infection and why. Effectiveness of this method of presentation: Excellent Very good Good Fair Poor I Yes I No 4. Discuss current and new prophylactic options for managing RSV. 5 4 3 2 1 I Yes I No What other topics would you like to see addressed? Comments: 5. Establish educational initiatives to raise the awareness of parents and health care professionals about the prevention and treatment of RSV. I Yes I No 6. Assess best practices in a managed care setting for managing RSV, so as to improve outcomes. I Yes I No T8M16-MG 20 MANAGED CARE / SUPPLEMENT

Table of Contents Feed for the Digital Edition of Managed Care - November 2008

Managed Care - November 2008 Editor’s Memo Contents News and Commentary Legislation & Regulation Letters Medication Management Compensation Monitor Do It Yourself for Less Biomarkers Promise, but Do They Deliver? Oncologists Complain About Drug Payment Consider Blood Pressure Self-Monitoring Q&A: Keep Industry in the Game Formulary Files Plan Watch Tomorrow’s Medicine Outlook Respiratory Syncytial Virus Managed Care Considerations Contents Continuing Education Objectives RSV Disease in the Pediatric Population In the Trenches RSV Infection in the Adult Population Health Plan Medical Director Health Plan Pharmacy Director RSV Issues and Solutions Assessment/Evaluation/Certificate Request Post-Test

Managed Care - November 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.